Evaluation of cardiac manifestations in pediatric liver transplant candidates

Pediatr Transplant. 2012 Jun;16(4):318-28. doi: 10.1111/j.1399-3046.2012.01667.x. Epub 2012 Mar 16.

Abstract

Knowledge concerning the involvement of the cardiovascular system in children awaiting liver transplant is limited. Therefore, no guidelines have been established on evaluating this group of patients for cardiac disease. This review examines the diverse cardiovascular manifestations of liver disease in children. We also discuss the available testing and its applicability in screening for cardiac disease in this vulnerable population.

Publication types

  • Review

MeSH terms

  • Alagille Syndrome / complications
  • Alagille Syndrome / surgery
  • Biliary Atresia / complications
  • Biliary Atresia / surgery
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / etiology
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / etiology*
  • Child
  • End Stage Liver Disease / complications*
  • End Stage Liver Disease / surgery
  • Hemangioendothelioma / complications
  • Hemangioendothelioma / surgery
  • Hepatopulmonary Syndrome / diagnosis
  • Hepatopulmonary Syndrome / etiology
  • Humans
  • Hypertension, Portal / diagnosis
  • Hypertension, Portal / etiology
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / etiology
  • Liver Neoplasms / complications
  • Liver Neoplasms / surgery
  • Liver Transplantation*
  • Long QT Syndrome / diagnosis
  • Long QT Syndrome / etiology
  • Metabolism, Inborn Errors / complications
  • Metabolism, Inborn Errors / surgery